Dosidal · Switzerland
Adempas junior, Granulat zur Herstellung einer Suspension zum Einnehmen
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69929 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69929 atc: C02KX05 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2025-11-04 term: zugelassen valid_until: 2030-11-03 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: C02KX05 authorisation_number: 69929 form: GRAS holder: Bayer (Schweiz) AG holder_partner_nr: 1000372 it_number: 02.07.1. name: Adempas junior, Granulat zur Herstellung einer Suspension zum Einnehmen state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53mNj1ANvsESwCfaEUmrjddisUSfEz85inKpuIhZv88YTbqkyuGdHsDrAQKY04klQm1bEYmG9nkGwPzBbaBC7ZkwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |